FOXO1 and hyperlipidemia: Using this approach, Banerjee et al. successfully demonstrated that the combination of these techniques can analyze the lead compounds of the extracts and identify relevant signaling pathways, such as the IRS/Akt/Foxo1 cascade, targeting hyperlipidemia [58].